| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.02 |